INERTIA
Suboptimal blood pressure control is driven in part by clinical inertia, or the failure to intensify treatment when indicated. Interventions to overcome inertia have been only modestly successful perhaps because they have been insufficiently targeted to primary care providers. This three-arm randomized pragmatic trial was conducted at Massachusetts General Hospital and involved 45 primary care providers and 466 patients. It is testing the effect on treatment intensification of a social marketing-based pharmacist e-consult and a social norming intervention. It will also identify characteristics of patients, providers, and their interactions to understand for whom each intervention would be most beneficial. Results will be published in the spring of 2024.
ClinicalTrials.gov: NCT04603560
Co-Principal Investigators: Nancy Haff, MD, MPH and Niteesh Choudhry, MD, PhD
Personalizing intervention to reduce clinical inertia in the treatment of hypertension
Haff N, Wood W, Yom-Tov E, , Lauffenburger JC, Sreedhara SK, Fontanet CF, Kim E, Hanken K, Barlev RA, Choudhry NK
in peer review
Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial
Haff N, Sreedhara SK, Wood W, Yom-Tov E, Horn DM, Hoover M, Low G, Lauffenburger JC, Chaitoff A, Russo M, Hanken K, Crum KL, Fontanet CP, Choudhry NK
2023 November 13